N-acetylcysteine reduces infarct size

An inexpensive drug delivered promptly to patients with ST-elevated myocardial infarction (STEMI) reduces infarct size by about a third compared to standard treatment with PCI alone, cardiologists in Adelaide have found. Results from the NACIAM trial involving 112 STEMI patients showed that the addition of IV N-acetylcysteine (NAC) to low dose glyceryl trinitrate (GTN) given to STEMI ...

Already a member?

Login to keep reading.

© 2021 the limbic